2013
DOI: 10.1016/j.cireng.2014.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic Metastasis Marking Before Neoadjuvant Chemotherapy for Their Subsequent Location and Resection Using Non-anatomical Hepatectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…4 Marking CRLM should be considered in some situations; In patients with CRLM at risk of becoming missing after systemic neoadjuvant or ablative treatment and in lesions which characteristics make their intraoperative ultrasound detectability difficult such as small intraparenchymal lesions, hypoechogenic lesions or mild/ severe liver steatosis. 6,7 Casado et al 7 used percutaneous placement of marking coils CT guided before neoadjuvant therapy in the deep margin of a CRLM located in the intersection of segments V-VI-VII-VIII. After neoadjuvant the lesion had disappeared, intraoperative ultrasound showed marking coil, allowing them to carry out a non-anatomic liver resection.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…4 Marking CRLM should be considered in some situations; In patients with CRLM at risk of becoming missing after systemic neoadjuvant or ablative treatment and in lesions which characteristics make their intraoperative ultrasound detectability difficult such as small intraparenchymal lesions, hypoechogenic lesions or mild/ severe liver steatosis. 6,7 Casado et al 7 used percutaneous placement of marking coils CT guided before neoadjuvant therapy in the deep margin of a CRLM located in the intersection of segments V-VI-VII-VIII. After neoadjuvant the lesion had disappeared, intraoperative ultrasound showed marking coil, allowing them to carry out a non-anatomic liver resection.…”
Section: Discussionmentioning
confidence: 99%
“…Marking CRLM should be considered in some situations; In patients with CRLM at risk of becoming missing after systemic neoadjuvant or ablative treatment and in lesions which characteristics make their intraoperative ultrasound detectability difficult such as small intraparenchymal lesions, hypoechogenic lesions or mild/severe liver steatosis. 6,7…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation